MITHRIL II LP → Adagio Therapeutics, Inc. IVVD

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

7 13D/G filings on this issuer

6 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 8.44

26,469,699 shares short · +7.9% vs prior

Other 13D/G Filings on Adagio Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2025-12-29	SCHEDULE	Adimab, LLC	7.30%	20,262,170	view →
2025-11-12	SCHEDULE	MITHRIL II LP	4.80%	11,241,580	view →
2025-11-07	SCHEDULE	Polaris Venture Partners V, L.P.	3.00%	7,008,590	view →
2024-01-22	SC	Adimab, LLC	—	—	view →
2022-07-05	SC	MITHRIL II LP	—	—	view →
2022-03-30	SC	Polaris Venture Partners V, L.P.	—	—	view →

Other Filings by MITHRIL II LP

Filed	Form	Issuer	Stake	Shares
2025-11-12	SCHEDULE	Invivyd, Inc. IVVD	4.80%	11,241,580	view →
2022-07-05	SC	Adagio Therapeutics, Inc. IVVD	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →